PAB — Cytomegalovirus (Cmv) Dna Quantitative Assay Class II

FDA Device Classification

Classification Details

Product Code
PAB
Device Class
Class II
Regulation Number
866.3180
Submission Type
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Definition

Cytomegalovirus (CMV) DNA Quantitative Assay is an in vitro nucleic acid assay for the quantitative measurement of CMV DNA in human plasma. The assay can be used to measure CMV DNA levels serially at baseline and during the course of antiviral treatment to assess virological response to treatment. The test results must be interpreted within the context of all relevant clinical and laboratory findings.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K252481roche molecular systemscobas CMVNovember 3, 2025
K243485abbott molecularAlinity m CMVJuly 1, 2025
K243935hologicAptima CMV Quant AssayJanuary 17, 2025